$1.83
0.2616.88%
Últ. Act.: Oct 2, 2:59 PM
$1.66
0.095.73%
Nautilus Biotechnology (NAUT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.14 | $-0.14 | $-0.14 | $-0.15 |
| Actual | $-0.11 | $-0.12 | $-0.11 | $-0.11 |
| Surprise | +21.4% | +14.3% | +21.4% | +26.7% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $190000 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.14 | $-0.13 |
| Revenue | ||
| Consensus | $208330 | $210000 |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 28, 2026 | $-0.11 | $-0.14 | 21.4 % |
| Q1 | Apr 28, 2026 | $-0.12 | $-0.14 | 14.3 % |
| Q4 | Feb 26, 2026 | $-0.11 | $-0.14 | 21.4 % |
| Q3 | Oct 28, 2025 | $-0.11 | $-0.15 | 26.7 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q1 | May 3, 2022 | $0 | $170.00K | -100.0 % |